At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
8-K current report May 22, 2013 36.8 KB View HTML View PDF View XLS  
10-Q quarterly report May 9, 2013 360.3 KB View HTML View PDF View XLS View XBRL  
8-K current report May 9, 2013 1.0 MB View HTML View PDF View XLS  
DEF 14A definitive proxy statement Apr 26, 2013 702.6 KB View HTML View PDF View XLS  
8-K current report Apr 24, 2013 71.8 KB View HTML View PDF View XLS  
4 crowley, john f Mar 18, 2013 24.7 KB View HTML View PDF View XLS  
4 barer, sol j Mar 18, 2013 24.2 KB View HTML View PDF View XLS  
10-K annual report Mar 13, 2013 1.1 MB View HTML View PDF View XLS View XBRL  
8-K current report Mar 12, 2013 1.1 MB View HTML View PDF View XLS  
8-K current report Feb 22, 2013 22.5 KB View HTML View PDF View XLS  
SC 13G/A amended statement of beneficial ownership Feb 14, 2013 48.3 KB View HTML View PDF View XLS  
SC 13G/A amended statement of beneficial ownership Feb 14, 2013 25.9 KB View HTML View PDF View XLS  
SC 13G/A amended statement of beneficial ownership Feb 14, 2013 81.4 KB View HTML View PDF View XLS  
3 macaluso peter m Feb 11, 2013 29.1 KB View HTML View PDF View XLS  
3 gershkowitz jayne Feb 11, 2013 29.9 KB View HTML View PDF View XLS  
3 castelli jeff Feb 11, 2013 30.2 KB View HTML View PDF View XLS  
4 kirk, john Jan 30, 2013 24.4 KB View HTML View PDF View XLS  
4 dilone, enrique Jan 30, 2013 22.9 KB View HTML View PDF View XLS  
4 valenzano, ken Jan 30, 2013 22.9 KB View HTML View PDF View XLS  
4 peist, kenneth Jan 30, 2013 22.9 KB View HTML View PDF View XLS  
Showing 1-20 of 639 Page: 1 2 3 4 5 ... 32  Next 20

Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy